Biochemical characterisation of the CTX-M-14 β-lactamase

International Journal of Antimicrobial Agents - Tập 29 - Trang 159-164 - 2007
Yoshikazu Ishii1,2, Moreno Galleni1, Ling Ma2, Jean-Marie Frère1, Keizo Yamaguchi2
1Centre for Protein Engineering, University of Liège, B6 Institute of Chemistry, Sart Tilman, B4000 Liège, Belgium
2Department of Microbiology and Infectious Diseases, Toho University Faculty of Medicine, 5-21-16 Omori-nishi, Ota-ku, 1438540 Tokyo, Japan

Tài liệu tham khảo

Ambler, 1991, A standard numbering scheme for the class A β-lactamases, Biochem J, 276, 269, 10.1042/bj2760269 Forsman, 1990, Molecular analysis of β-lactamases from four species of Streptomyces: comparison of amino acid sequences with those of other β-lactamases, J Gen Microbiol, 136, 589, 10.1099/00221287-136-3-589 Mossakowska, 1989, Oxacillin-hydrolysing β-lactamases. A comparative analysis at nucleotide and amino acid sequence levels, Eur J Biochem, 180, 309, 10.1111/j.1432-1033.1989.tb14649.x Bonnet, 2004, Growing group of extended-spectrum β-lactamases: the CTX-M enzymes, Antimicrob Agents Chemother, 48, 1, 10.1128/AAC.48.1.1-14.2004 Bradford, 2001, Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat, Clin Microbiol Rev, 14, 933, 10.1128/CMR.14.4.933-951.2001 Jacoby, 2005, The new β-lactamases, N Engl J Med, 352, 380, 10.1056/NEJMra041359 Walther-Rasmussen, 2004, Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases, Can J Microbiol, 50, 137, 10.1139/w03-111 Ma, 2002, CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum β-lactamase isolated from Escherichia coli, Antimicrob Agents Chemother, 46, 1985, 10.1128/AAC.46.6.1985-1988.2002 Ishii, 2005, Extended-spectrum β-lactamase-producing Shiga toxin gene (Stx1)-positive Escherichia coli O26:H11: a new concern, J Clin Microbiol, 43, 1072, 10.1128/JCM.43.3.1072-1075.2005 Izumiya, 2005, Identification of CTX-M-14 β-lactamase in a Salmonella enterica serovar Enteritidis isolate from Japan, Antimicrob Agents Chemother, 49, 2568, 10.1128/AAC.49.6.2568-2570.2005 Kojima, 2005, Extended-spectrum-β-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program, Antimicrob Agents Chemother, 49, 3533, 10.1128/AAC.49.8.3533-3537.2005 Shiraki, 2004, Escherichia coli producing CTX-M-2 β-lactamase in cattle, Japan, Emerg Infect Dis, 10, 69, 10.3201/eid1001.030219 Ahmed, 2004, The first characterization of extended-spectrum β-lactamase-producing Salmonella in Japan, J Antimicrob Chemother, 54, 283, 10.1093/jac/dkh300 Bonnet, 2001, Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly, Antimicrob Agents Chemother, 45, 2269, 10.1128/AAC.45.8.2269-2275.2001 Kimura, 2004, Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis, Antimicrob Agents Chemother, 48, 1454, 10.1128/AAC.48.5.1454-1460.2004 Poirel, 2001, CTX-M-type extended-spectrum β-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop, Antimicrob Agents Chemother, 45, 3355, 10.1128/AAC.45.12.3355-3361.2001 Ibuka, 2003, Crystal structure of extended-spectrum β-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion, Biochemistry, 42, 10634, 10.1021/bi0342822 Ma, 2002, Characterization of cefotaxime-resistant Escherichia coli isolates from a nosocomial outbreak at three geriatric hospitals, J Infect Chemother, 8, 155, 10.1007/s101560200027 Alba, 2003, A detailed kinetic study of Mox-1, a plasmid-encoded class C β-lactamase, FEMS Microbiol Lett, 225, 183, 10.1016/S0378-1097(03)00448-8 De Meester, 1987, Automated analysis of enzyme inactivation phenomena. Application to β-lactamases and DD-peptidases, Biochem Pharmacol, 36, 2393, 10.1016/0006-2952(87)90609-5 Fersht, 1999, The basic equations of enzyme kinetics Frere, 1982, Interaction of clavulanate with the β-lactamases of Streptomyces albus G and Actinomadura R39, Biochem J, 207, 429, 10.1042/bj2070429 Chen, 2005, Atomic resolution structures of CTX-M β-lactamases: extended spectrum activities from increased mobility and decreased stability, J Mol Biol, 348, 349, 10.1016/j.jmb.2005.02.010 Richmond, 1981, The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of β-lactamases from clinically relevant bacterial species, J Antimicrob Chemother, 7, 279, 10.1093/jac/7.3.279 Babini, 1998, Interactions of β-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral β-lactams, Antimicrob Agents Chemother, 42, 1168, 10.1128/AAC.42.5.1168 Nagano, 2003, Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-lactamase, J Clin Microbiol, 41, 5530, 10.1128/JCM.41.12.5530-5536.2003 Yang, 2000, Mechanism of inhibition of the class A β-lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry, J Biol Chem, 275, 26674, 10.1016/S0021-9258(19)61429-8 Kuzin, 2001, Inhibition of the SHV-1 β-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam, Biochemistry, 40, 1861, 10.1021/bi0022745 Spanu, 2002, Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs, Antimicrob Agents Chemother, 46, 196, 10.1128/AAC.46.1.196-202.2002